Regulatory role for macrophage migration inhibitory factor in acute respiratory distress syndrome

Nature Medicine

Volumn 3, Issue 3, 1997, Pages 320-323

  Donnelly, Seamas C ^a   Haslett, Chris ^a   Reid, Peter T ^a   Grant, Ian S ^b   Wallace, William A H ^a   Metz, Christine N ^c   Bruce, Lorna J ^a   Bucala, Richard ^c  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b WESTERN GENERAL HOSPITAL   (United Kingdom)

^c PICOWER INST FOR MEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; INTERLEUKIN 8; MIGRATION INHIBITION FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; LUNG ALVEOLUS; LUNG ALVEOLUS MACROPHAGE; PRIORITY JOURNAL;

CELLS, CULTURED; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT, NEWBORN; INTERLEUKIN-8; LUNG; MACROPHAGE MIGRATION-INHIBITORY FACTORS; RESPIRATORY DISTRESS SYNDROME, NEWBORN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031052013     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0397-320     Document Type: Article

References (23)

1. Bloom, B.R. & Bennett, B. Mechanism of a reaction in vitro associated with delaye type hypersensitivity. Science 153, 80-82 (1966).
2. David, J. Delayed hypersensitivity in vitro: Its mediation by cell free substances formed by lymphoid cell-antigen interaction. Proc Natl. Acad. Sci. USA 56, 72-77 (1966).
3. Bernhagen, J. et al. MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature 365, 756-759 (1993).
4. Calandra, T., Bernhagen, J., Mitchell, R.A. & Bucala, R. The macrophage is an important and previously unrecognized source of macrophage migratory inhibitory factor. J. Exp. Med. 179, 1895-1901 (1994).
5. Bernhagen, J. et al. Purification, bioactivity, and secondary structure analysis of mouse and human macrophage migration inhibitory factor (MIF). Biochemistry 33, 14144-14155 (1994).
6. Nishino, T. et al. Localisation of macrophage migration inhibitory factor (MIF) to secretory granules within the corticotrophic and thyrotrophic cells of the pituitary gland. Mol. Med. 1, 781-788 (1995).
7. Calandra, T. et al. MIF as a glucocorticoid-induced modulator of cytokin production. Nature 377, 68-71 (1995).
8. Warshawski, J., Sibbald, W.J., Driedger, A.A. & Cheung, H. Abnormal neutrophil-pulmonary interaction in the adult respiratory distress syndrome. Am. Rev. Resp. Dis. 133, 797-804 (1986).
9. Donnelly, S.C. et al. Plasma elastase in multiple trauma and the adult respiratory distress syndrome (ARDS). Am. J. Respir. Crit. Care. Med. 151, 1428-1433 (1995).
10. Donnelly, S.C. et al. Interleukin 8 (IL-8) and the development of the adult respiratory distress syndrome (ARDS) in at-risk patient groups. Lancet. 341, 643-647 (1993).
11. Suter, P.M. et al. High bronchoalveolar levels of tumor necrosis factor and its inhibitors, interleukin-1, interferon and elastase, in patients with adult respiratory distress syndrome after trauma, shock or sepsis. Am. Rev. Resp. Dis. 145, 1016-1022 (1992).
12. Rocker, G.M., Wiseman, M.S., Pearson, D. & Shale, D.J. Diagnostic criteria for adult respiratory distress syndrome: time for reappraisal. Lancet i, 120-123 (1989).
13. Christner, P., et al. Collagenase in the lower respiratory tract of patients with the adult respiratory distress syndrome. Am Rev Resp. Dis. 131, 690-695 (1985).
14. Baldwin, S.R. et al. Oxidant activity in expired air of patients with adult respiratory distress syndrome. Lancet i, 11-13 (1986).
15. Sekido, N. et al. Prevention of lung perfusion injury in rabbits by a monoclonal antibody against interleukin-8. Nature 365, 654-657 (1993).
16. Folkesson, H.G. et al. Acid aspiration induced lung injury in rabbits is mediated by interleukin-8-dependant mechanisms. J. Clin. Invest. 96, 107-116 (1995).
17. Barnes, P.J., Greening, A.P. & Crompton, G.K. Glucocorticoid resistance in asthma. Am. J. Respir. & Crit. Care Med. 152, S125-S142 (1995).
18. Bernard, G.R. et al. High-dose corticosteroids in patients with the adult respiratory distress syndrome. N. Engl. J. Med. 317, 1365-1370 (1987).
19. Luce, J.M. et al. Ineffectiveness of high-dose methylprednisolone in preventing parenchymal lung injury and improving mortality in patients with septic shock. Am. Rev. Respir. Dis. 138, 62-68 (1988).
20. Meduri, G.M. et al. Corticosteroid rescue treatment of progressive fibro-proliferation in late ARDS. Chest 105, 1516-1527 (1994).
21. Ashbaugh, D.G. & Maier, R.V. Idiopathic pulmonary fibrosis in adult respiratory distress syndrome. Arch. Surg. 120, 530-535 (1990).
22. Hooper, R.G. & Kearl, R.A. Established ARDS treated with a sustained course of adrenocortical steroids. Chest 97, 138-143 (1990).
23. Bernard, G.R. et al. The American-European Consensus Conference on ARDS: Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am. J. Respir. Crit. Care Med. 149, 818-824 (1994).